Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:789298.
doi: 10.1155/2015/789298. Epub 2015 Aug 17.

Prognostic Implications of Serum Lipid Metabolism over Time during Sepsis

Affiliations

Prognostic Implications of Serum Lipid Metabolism over Time during Sepsis

Sang Hoon Lee et al. Biomed Res Int. 2015.

Abstract

Background: Despite extensive research and an improved standard of care, sepsis remains a disorder with a high mortality rate. Sepsis is accompanied by severe metabolic alterations.

Methods: We evaluated 117 patients with sepsis (severe sepsis [n = 19] and septic shock [n = 98]) who were admitted to the intensive care unit. Serum cholesterol, triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), free fatty acid (FFA), and apolipoprotein (Apo) A-I levels were measured on days 0, 1, 3, and 7.

Results: Nonsurvivors had low levels of cholesterol, TG, HDL, LDL, and Apo A-I on days 0, 1, 3, and 7. In a linear mixed model analysis, the variations in TG, LDL, FFA, and Apo A-I levels over time differed significantly between the groups (p = 0.043, p = 0.020, p = 0.005, and p = 0.015, resp.). According to multivariate analysis, TG levels and SOFA scores were associated with mortality on days 0 and 1 (p = 0.018 and p = 0.008, resp.).

Conclusions: Our study illustrated that TG levels are associated with mortality in patients with sepsis. This may be attributable to alterations in serum lipid metabolism during sepsis, thus modulating the host response to inflammation in critically ill patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of the inclusion and exclusion of patients in the study. A total of 179 patients were enrolled between August and December 2008, and 117 patients were included in the analysis. Patients who were being admitted for a second time (n = 4), those using steroids (n = 26), and those with a history of dyslipidemia (n = 13) or liver disease (n = 22) were excluded. Note: one patient had dyslipidemia and liver disease and two patients had liver disease and used steroids (≥15 mg/day) within the previous 7 days.
Figure 2
Figure 2
Time course of lipid levels in the survivor and nonsurvivor groups. Data for cholesterol (a), triglyceride (b), high-density lipoprotein (c), low-density lipoprotein (d), free fatty acid (e), and apolipoprotein A-I (f) are shown. Data were collected on the day of admission and days 1, 3, and 7 after admission. The circle and bar represent the mean value and standard error of the mean, respectively. Significant differences between the survivor and nonsurvivor groups are indicated by .
Figure 3
Figure 3
Receiver operator characteristic (ROC) curves of triglyceride levels and Sequential Organ Failure Assessment (SOFA) scores to predict mortality. On the day of admission, the area under curve for triglyceride levels was 0.62 (sensitivity = 94.7%, specificity = 29.6, and p = 0.066), and that for the SOFA score was 0.63 (sensitivity = 21.2%, specificity = 96.9, and p = 0.019). In addition, adjusting for triglyceride levels with the SOFA score significantly improved the predictive accuracy of 28-day mortality (AUC = 0.716, sensitivity = 71.1%, specificity = 66.7%, and p < 0.001).

Similar articles

Cited by

References

    1. Kaukonen K.-M., Bailey M., Suzuki S., Pilcher D., Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. Journal of the American Medical Association. 2014;311(13):1308–1316. doi: 10.1001/jama.2014.2637. - DOI - PubMed
    1. Lagu T., Rothberg M. B., Shieh M.-S., Pekow P. S., Steingrub J. S., Lindenauer P. K. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Critical Care Medicine. 2012;40(3):754–761. doi: 10.1097/CCM.0b013e318232db65. - DOI - PubMed
    1. Angus D. C., van der Poll T. Severe sepsis and septic shock. The New England Journal of Medicine. 2013;369(21):p. 2063. - PubMed
    1. Cetinkaya A., Erden A., Avci D., et al. Is hypertriglyceridemia a prognostic factor in sepsis? Therapeutics and Clinical Risk Management. 2014;10(1):147–150. doi: 10.2147/tcrm.s57791. - DOI - PMC - PubMed
    1. Van Leeuwen H. J., Heezius E. C. J. M., Dallinga G. M., van Strijp J. A. G., Verhoef J., van Kessel K. P. M. Lipoprotein metabolism in patients with severe sepsis. Critical Care Medicine. 2003;31(5):1359–1366. doi: 10.1097/01.ccm.0000059724.08290.51. - DOI - PubMed

LinkOut - more resources